Analyze Your Search


  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Cardiovascular Pharmacology
  Follow Topic   Edit Search
Your search returned 7 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
Lancet (London, England) 
... Elderly patients regularly receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of double antiplatelet therapy (DAPT ... Exclusion criteria were indication for myocardial revascularisation by coronary artery bypass grafting; inability to tolerate, obtain, or comply with DAPT; requirement for additional surgery; non-cardiac comorbidities with a life expectancy of less than 1 year; previous haemorrhagic stroke; allergy to aspirin or P2Y12 inhibitors; contraindication to P2Y12 inhibitors; and silent ischaemia ... sizes [two, four, eight, or 16]; stratified by site and antiplatelet agent) to either a DES or similar BMS in a single ...
Senior Health (4), Cardiovascular Diseases (4)
Myocardial Infarction (2), Thrombosis (1), Allergy (1), more mentions
The Cochrane database of systematic reviews 
Recently developed direct oral anticoagulants (DOAC) are expected to be useful as alternatives to warfarin AbstractText: To assess the efficacy and safety of DOAC including apixaban, dabigatran, edoxaban, and rivaroxaban versus warfarin among AF patients with CKD AbstractText: We searched the Cochrane ... which directly compared the efficacy and safety of direct oral anticoagulants (direct thrombin inhibitors or factor Xa inhibitors) with dose-adjusted warfarin for preventing stroke and systemic embolic events in non-valvular ...
Cardiovascular Diseases (7), Kidney Disease (2)
Stroke (2), Atrial Fibrillation (2), Chronic Kidney Diseases (2), more mentions
Abstract: Background -Current guidelines recommend non-vitamin-K antagonist oral anticoagulants (NOACs) as the first choice therapy in patients with non-valvular atrial fibrillation, as these drugs have several benefits over the vitamin-K antagonists (VKA ... VKA to treat patients with non-valvular AF and concomitant aspirin therapy Keyword: anticoagulation.
Cardiovascular Diseases (5)
Atrial Fibrillation (3), Intracranial Hemorrhages (2), Stroke (2), more mentions
4. Diuretic Treatment in Heart Failure.  
Date: 11/15/2017
The New England journal of medicine 
Diuretic Treatment in Heart Failure..
Heart Failure (2), more mentions
Lancet (London, England) 
Factor Xa inhibitors and aspirin each reduce thrombotic events but have not yet been tested ... Rivaroxaban plus aspirin reduced mortality when compared with aspirin alone (262 [3%] of 8313 vs 339 [4%] of 8261 ... 0·90, p=0·0012) AbstractText: In patients with stable coronary artery disease, addition of rivaroxaban to aspirin lowered major vascular events, but increased major bleeding ...
Cardiovascular Diseases (1)
Coronary Artery Disease (10), Myocardial Infarction (2), Unstable Angina (1), more mentions
The American journal of cardiology 
Abstract: Although aspirin monotherapy is considered the standard of care after coronary artery bypass grafting (CABG), more recent evidence has suggested a ... At a mean follow-up of 23 months, major adverse cardiac events (10.3% vs 12.1%, RR 0.84, confidence interval [CI] 0.71 ... CI 0.63 to 0.98) were less with DAPT than with aspirin monotherapy.
Cardiovascular Diseases (3)
Acute Coronary Syndrome (2), Myocardial Infarction (1), more mentions
European heart journal 
... new dementia in patients with AF with and without oral anticoagulants, and to explore if there is a difference between novel anticoagulants and warfarin in this respect AbstractText: Retrospective registry study of all patients ... Direct comparison between new oral anticoagulants and warfarin showed no difference (HR 0.97, 95% CI 0.67-1.40) AbstractText: The risk of dementia is higher without oral anticoagulant treatment in patients with AF ...
Neuroscience (7), Cardiovascular Diseases (3)
Dementia (7), Atrial Fibrillation (3), more mentions